Twitter Facebook LinkedIn YouTube

NeutriSci International expands its partnerships with Cryopharm and Nutritional High International

Video Platform Video Management Video Solutions Video Player

NeutriSci previously licensed its Cryolization technology to Cryopharm for the manufacturing and distribution of buccal and sublingual rapid release consumable products utilizing both CBD and THC molecules. Under the expanded terms, Cryopharm will manufacture NeutriSci's ZenStix and Dablets in addition to manufacturing its own product, Marbl Melts.

Additional Information:

Company: NeutriSci International Inc.
Website: http://www.NeutriSci.com
Stock Symbol: TSXV: NU
Date Published: Sep 12, 2019
Transcript: Available

Video Transcript:

I’m Nadika Viswakula for Investmentpitch Media

NeutriSci International Inc. has expanded its partnerships with Cryopharm Corp. and Nutritional High International Inc.

NeutriSci previously licensed its Cryolization technology to Cryopharm for the manufacturing and distribution of buccal and sublingual rapid release consumable products utilizing both CBD and THC molecules.

Under the expanded terms, Cryopharm will manufacture NeutriSci's ZenStix and Dablets in addition to manufacturing its own product, Marbl Melts.

Cryopharm purchases the core ingredients for its Marbl Melts from NeutriSci and under the licensing terms, pays NeutriSci a license fee, and a royalty on gross sales.

With production facilities in Sacramento, California, Cryopharm is a licensed THC manufacturer and distributor of medical grade, dose-controlled recreational and medicinal cannabis products.

Nutritional High's subsidiary, Calyx Brands, will distribute Marbl Melts, Zenstix and Dablets, along with its other brands to its network of nearly 600 retailers throughout the State of California.

Glen Rehman, CEO, stated: "We are very pleased to announce the manufacturing of our Zenstix and Dablet sublingual melts, using NeutriSci's patent pending Cryolization technology through Cryopharm. We are pleased with these partnerships as they offer NeutriSci the ability to get our product on the shelves quickly and efficiently. Cryopharm is part of a small and select group of companies that is fully licensed to manufacture and infuse cannabis in the state of California, and Calyx Brands is the leader in edible distribution in California. They have a proven track record of helping turn edibles brands into household names. With their 500+ store reach and impressive sales platform, we look forward to them doing the same for us."

Ryan Erving, COO of Cryopharm, commented: "We are excited to partner with NeutriSci and Nutritional High for the production and sale of our Marbl Melts, and the Dablet and Zenstix line of products. This partnership allows Cryopharm and NeutriSci to get their products on the dispensary shelf quickly and efficiently, while also offering a strong revenue stream for all companies."

Dakota Sullivan, CEO of Calyx Brands, added: "We're thrilled to be launching NeutriSci and Cryopharm products this fall. The edibles market has become dominated by line extensions and me-too type products. At the same time, consumers are becoming more and more comfortable with infused products and are hungry to try something they haven't seen before. NeutriSci and Cryopharm are blazing new trails with fast-acting, quick-dissolving cannabis marbles and great tasting chewable melts. Retailers across the state will be very interested in these innovative new products."

Established in 2009, NeutriSci currently sells its neuenergy® energy bar in more than 7,600 retail outlets across Canada.

The shares are trading at $0.06.

For more information, please visit the company’s website at www.NeutriSci.com, contact Glen Rehman, CEO, at 403-264-6320 or email investors@NeutriSci.com.

I’m Nadika Viswakula for Investmentpitch Media